Cargando…
Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
Acute respiratory distress syndrome (ARDS), resulting from an exaggerated inflammatory response, is the main cause of death from the coronavirus disease 2019 (COVID-19). Apart from respiratory infection, COVID-19 patients can develop cardiovascular disorders such as myocardial injury and myocarditis...
Autores principales: | Torres-Peña, Jose D., Katsiki, Niki, Perez-Martinez, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578478/ https://www.ncbi.nlm.nih.gov/pubmed/34778421 http://dx.doi.org/10.3389/fcvm.2021.775749 |
Ejemplares similares
-
Off target effects of statins shape total mortality?
por: Athyros, Vasilios G., et al.
Publicado: (2016) -
Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021) -
Early carbohydrate antigen 125 as a mortality predictor in hospitalized patients with coronavirus disease 2019
por: Moreno-Perez, Oscar, et al.
Publicado: (2022) -
Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022) -
More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)